No CrossRef data available.
Article contents
Coloniality of Waithood: Africa’s Wait for COVID-19 Vaccines amid COVAX and TRIPS
Published online by Cambridge University Press: 19 January 2023
Abstract
African nations have struggled to secure lifesaving COVID-19 vaccines, while rich nations have purchased more than they needed, depleting the global supply. High vaccine prices and intellectual property regulations that block the production of cheaper generics have contributed to a condition of African waithood. Hagan examines this waithood, which characterizes the disjuncture between African countries’ existential and humanitarian need for COVID-19 vaccines and corporations’ quest for profits in the pandemic. African waithood, produced by pharmaceutical companies including Moderna and Pfizer, is a direct product of colonialism. Waithood echoes the ongoing colonial relations between African nations and the corporations that continue to exploit them.
Résumé
Les pays africains ont eu du mal à obtenir des vaccins vitaux contre la COVID-19, tandis que les pays riches ont acheté plus que nécessaire, épuisant ainsi l’approvisionnement mondial. Les prix élevés des vaccins et les réglementations en matière de propriété intellectuelle qui bloquent la production de génériques moins chers ont contribué à une condition africaine d’attente. Hagan examine cette attente, qui caractérise la disjonction entre le besoin existentiel et humanitaire des pays africains en vaccins contre la COVID-19 et la quête de profits des entreprises dans la pandémie. Cette condition africaine d’attente produit par des sociétés pharmaceutiques telles que Moderna et Pfizer, représente un exemple de colonialisme concret. Cette attente africaine fait écho aux relations coloniales en cours entre les nations africaines et les entreprises qui continuent de les exploiter.
Resumo
As nações africanas têm tido dificuldade em assegurar a obtenção das vacinas contra a COVID-19, essenciais para salvar vidas, ao passo que as nações ricas compraram mais vacinas do que precisam, depauperando a oferta mundial. O preço elevado das vacinas e a legislação relativa aos direitos de propriedade intelectual que impedem a produção de genéricos baratos contribuíram para deixar o continente africano em compasso de espera. Hagan analisa este compasso de espera, o qual traduz, por um lado, o desencontro entre a necessidade existencial e humanitária de vacinas contra a COVID-19 nos países africanos e, por outro lado, o empenho das corporações em fazerem o máximo lucro com a pandemia. O compasso de espera africano, criado por empresas farmacêuticas como a Moderna e a Pfizer, é um produto direto do colonialismo. O compasso de espera espelha as atuais relações coloniais entre as nações africanas e as corporações que continuam a explorá-las.
- Type
- Article
- Information
- Copyright
- © The Author(s), 2023. Published by Cambridge University Press on behalf of the African Studies Association
References
Adebisi, Yusuff Adebayo, Rabe, Adrian, and Lucero-Prisno, Don Eliseo III. 2021. “Risk communication and community engagement strategies for COVID-19 in 13 African countries.” Health Promotion Perspectives 11(2): 137.CrossRefGoogle ScholarPubMed
Adekunle, Tiwaladeoluwa B., and Mohammed, Wunpini Fatimata. 2022. “Communication in Context: How Culture, Structure, and Agency Shape Health and Risk Communication about COVID‐19 in Ghana.” World Medical & Health Policy.Google ScholarPubMed
Adepoju, Paul. 2021. “African Countries Reluctant to Borrow Funds for COVID-19 Vaccines.” Health Policy Watch. https://healthpolicy-watch.news/86305-2/.Google Scholar
Altindis, Emrah. 2022. “Inequitable COVID-19 vaccine distribution and the intellectual property rights prolong the pandemic.” Expert review of vaccines 21 (4): 427–30.CrossRefGoogle ScholarPubMed
Balaji, Aishu. 2021. “COVAX Protects the Vaccine Apartheid Status Quo.” Jacobin. https://jacobinmag.com/2021/05/COVID-covax-vaccine-apartheid-wto-trips-intellectual-property-ip.Google Scholar
Barton, John H. 2004. “TRIPS and the global pharmaceutical market.” Health affairs 23 (3): 146–54.CrossRefGoogle ScholarPubMed
Benton, Adia, Sangaramoorthy, Thurka, and Kalofonos, Ippolytos. 2017. “Temporality and Positive Living in the Age of HIV/AIDS: a Multisited Ethnography.” Current Anthropology 58 (4): 454–76.CrossRefGoogle ScholarPubMed
Bi, Suriyyah. 2020. “Racialisation of Rescuehood: Contextualising British Muslims Stuck Abroad during COVID-19 Pandemic.” Journal of British Muslim Studies.Google Scholar
Çakmaklı, Cem, Demiralp, Selva, Kalemli-Ozcan, Sebnem, Yeşiltaş, Sevcan, Yıldırım, Muhammed A.. 2021. “The Economic Case for Global Vaccination: an Epidemiological Model with International Production Networks.” https://iccwbo.org/content/uploads/sites/3/2021/02/2021-icc-summary-for-policymakers.pdf.CrossRefGoogle Scholar
Collier, Roger. 2013. “Drug Patents: the Evergreening Problem.” Canadian Medical Association Journal 185 (9): E385–E386.CrossRefGoogle ScholarPubMed
Correa, Carlos Maria. 2002. “Unfair competition under the TRIPS agreement: protection of data submitted for the registration of pharmaceuticals.” Chicago Journal of International Law 3: 69.Google Scholar
Dimier, Véronique. 2006. “Constructing Conditionality: the Bureaucratization of EC Development Aid.” European Foreign Affairs Review 11: 263.CrossRefGoogle Scholar
Dobler, Gregor. 2020. “Waiting: Elements of a Conceptual Framework.” Critical African Studies 12 (1): 10–21.CrossRefGoogle Scholar
Dunning, Thad. 2004. “Conditioning the Effects of Aid: Cold War Politics, Donor Credibility, and Democracy in Africa.” International organization 58 (2): 409–23.CrossRefGoogle Scholar
Durkin, Allison, Maria, Patricia Anne Sta, Willmore, Brandon, and Kapczynski, Amy. 2021. “Addressing the Risks That Trade Secret Protections Pose for Health and Rights.” Health and Human Rights 23 (1): 129.Google ScholarPubMed
Dwivedi, Gaurav, Hallihosur, Sharanabasava, and Rangan, Latha. 2010. “Evergreening: A Deceptive Device in Patent Rights.” Technology in Society 32 (4): 324–30.CrossRefGoogle Scholar
Dzinamarira, Tafadzwa, Nachipo, Brian, Phiri, Bright, and Musuka, Godfrey. 2021. “COVID-19 Vaccine Roll-out in South Africa and Zimbabwe: Urgent need to address community preparedness, fears and hesitancy.” Vaccines 9 (3): 250.CrossRefGoogle ScholarPubMed
Edsforth, Ronald. 2012. “On the definition of capitalism and its implications for the current global political-economic crisis.” In The International Conference on Cultural Diplomacy & the UN: “Cultural Diplomacy and Soft Power in an Interdependent World: The Opportunities for Global Governance.” New York and Washington, DC.Google Scholar
Elliot, Alice. 2021. The Outside: Migration as Life in Morocco. Bloomington: Indiana University Press.CrossRefGoogle Scholar
European Commission. 2011. The Entire Approach to EU Budget Support to Third Countries. Brussels: European Commission.Google Scholar
Fang, Lee. 2022. “Moderna Among Firms Quietly Granted Powers to Seize Patent Rights during Early Days of COVID Pandemic.” The Intercept. https://theintercept.com/2022/08/23/COVID-vaccine-patents-moderna-big-pharma-section-1498/.Google Scholar
Faye, Sylvain Landry B., Krumkamp, Ralf, Doumbia, Seydou, Tounkara, Moctar, Strauss, Ricardo, Ouedraogo, Henri Gautier, Sagna, Tani, Alpha M. Barry, Abdul K. Mbawah, Cheick O. Doumbia, Souleymane Diouf, Kadari Cissé, Mohamed Harding, Paule Donven, Jürgen May, Dewi I. Puradiredja, Daniela Fusco. 2022. “Factors influencing hesitancy towards adult and child COVID-19 vaccines in rural and urban West Africa: a cross-sectional study.” BMJ open 12 (4): e059138.CrossRefGoogle Scholar
Feldman, Robin. 2018. “May your Drug Price be Evergreen.” Journal of Law and the Biosciences 5 (3): 590–647.CrossRefGoogle Scholar
Ferguson, James. 1999. Expectations of Modernity: Myths and Meanings of Urban Life on the Zambian Copperbelt. Berkeley: University of California Press.Google Scholar
Figueroa, J. Peter, Bottazzi, Maria Elena, Hotez, Peter, Batista, Carolina, Onder Ergonul, Sarah Gilbert, Gursel, Mayda, et al. 2021. “Urgent needs of low-income and middle-income countries for COVID-19 vaccines and therapeutics.” The Lancet 397 (10274): 562–64.CrossRefGoogle Scholar
Fourcade, Marion, and Healy, Kieran. 2007. “Moral Views of Market Society.” Annual Review of Sociology 33: 285–311.CrossRefGoogle Scholar
Haakonsson, Stine Jessen, and Richey, Lisa Ann. 2007. “TRIPs and Public Health: the Doha Declaration and Africa.” Development Policy Review 25 (1): 71–90.CrossRefGoogle Scholar
Hassan, Fatima, London, Leslie, and Vawda, Yousuf. 2022. “The leaked WTO COVID patent waiver text promises a very bad deal.” Al Jazeera. https://www.aljazeera.com/opinions/2022/4/8/the-leaked-wto-COVID-patent-waiver-text-promises-a-very-bad-deal.Google Scholar
Haydon, Steph, Jung, Tobias, and Russell, Shona. 2021. “‘You’ve Been Framed’: A Critical Review of Academic Discourse on Philanthrocapitalism.” International Journal of Management Reviews 23 (3): 353–75.CrossRefGoogle Scholar
Honwana, Alcinda Manuel. 2012. The Time of Youth: Work, Social Change, and Politics in Africa. Sterling, Virginia: Kumarian Press.Google Scholar
Honwana, Alcinda Manuel. 2014. “2 ‘Waithood’: Youth Transitions and Social Change.” In Development and Equity, edited by Foeken, Dick, Dietz, Ton, de Haan, Leo, and Johnson, Linda, 28–40. Leiden: Brill.CrossRefGoogle Scholar
Inzaule, Seth C., Ondoa, Pascale, Loembe, Marguerite Massinga, Tebeje, Yenew Kebede, Ouma, Ahmed E. Ogwell, and Nkengasong, John N.. 2021. “COVID-19 and indirect health implications in Africa: Impact, mitigation measures, and lessons learned for improved disease control.” PLOS Medicine 18 (6): e1003666.CrossRefGoogle ScholarPubMed
Jefferson, Andrew M., and Segal, Lotte Buch. 2019. “The confines of time–On the ebbing away of futures in Sierra Leone and Palestine.” Ethnos 84 (1): 96–112.CrossRefGoogle Scholar
Jimenez, Darcy. 2021. “COVID-19: Vaccine Pricing Varies Wildly by Country and Company.” Pharmaceutical Technology. https://www.pharmaceutical-technology.com/analysis/COVID-19-vaccine-pricing-varies-country-company/.Google Scholar
Johnson, Sarah. 2022. “‘Like copying a Louis Vuitton handbag’: Big pharma hits out at Africa’s replica COVID vaccine.” The Guardian, October 5. https://www.theguardian.com/global-development/2022/oct/05/COVID-vaccine-inequity-south-africa-afrigen-mrna.Google Scholar
Karásková, Ivana, and Blablová, Veronika. 2021. “The Logic of China’s Vaccine Diplomacy.” The Diplomat. https://thediplomat.com/2021/03/the-logic-of-chinas-vaccine-diplomacy/.Google Scholar
Kavanagh, Matthew M., Erondu, Ngozi A., Tomori, Oyewale, Dzau, Victor J., Okiro, Emelda A., Maleche, Allan, Aniebo, Ifeyinwa C., Rugege, Umunya, Holmes, Charles B., and Gostin, Lawrence O.. 2020. “Access to lifesaving medical resources for African countries: COVID-19 testing and response, ethics, and politics.” The Lancet 395 (10238): 1735–38.CrossRefGoogle ScholarPubMed
Kollewe, Julia. 2022. “Pfizer accused of pandemic profiteering as profits double.” The Guardian. https://www.theguardian.com/business/2022/feb/08/pfizer-COVID-vaccine-pill-profits-sales.Google Scholar
Koprowski, Hilary. 2006. “First decade (1950–1960) of studies and trials with the polio vaccine.” Biologicals 34 (2): 81–86.CrossRefGoogle ScholarPubMed
Kretchmer, Harry. 2021. “Coronavirus: What is Vaccine Nationalism, How it Affects Us?” World Economic Forum. https://www.weforum.org/agenda/2021/01/what-is-vaccine-nationalism-coronavirus-its-affects-COVID-19-pandemic/.Google Scholar
Kumar, Arun, and Brooks, Sally. 2021. “Bridges, platforms and satellites: Theorizing the power of global philanthropy in international development.” Economy and Society 50 (2): 322–345.CrossRefGoogle Scholar
Langan, Mark. 2015. “Budget support and Africa–European Union relations: Free market reform and neo-colonialism?” European Journal of International Relations 21 (1): 101–21.CrossRefGoogle Scholar
The Lancet
. 2021. “Access to COVID-19 Vaccines: Looking beyond COVAX.”The Lancet (London, England) 397 (10278): 941.CrossRefGoogle Scholar
Lazare, Sarah. 2022a. “New “Compromise” on IP Waiver for COVID Vaccines Is Worse Than No Deal, Activists Say.” In These Times. https://inthesetimes.com/article/wto-trips-waiver-intellectual-property-biden-vaccines-diagnostics-treatments.Google Scholar
Lazare, Sarah. 2022b. “One Year Ago, Biden Promised to Support Generic Vaccines for the World. That’s Amounted to Nothing.” In These Times. https://inthesetimes.com/article/trips-waiver-wto-biden-COVID-vaccine-apartheid-south-africa-summit.Google Scholar
Lazare, Sarah, and Oamek, Paige. 2021. “Big Pharma’s Big Lie About Vaccine Patents.” In These Times. https://inthesetimes.com/article/pfizer-moderna-vaccine-apartheid-trips-waiver-wto-intellectual-property-patents.Google Scholar
Lee, Seow Ting. 2021. “Vaccine Diplomacy: Nation Branding and China’s COVID-19 Soft Power Play.” Place Branding and Public Diplomacy 1–15.CrossRefGoogle Scholar
Lewis, David, and Winning, David. 2021. “Exclusive: COVID-19 shots to cost $3 to $10 under African Union vaccine plan.” https://www.reuters.com/article/us-health-coronavirus-africa-vaccine-exc/exclusive-COVID-19-shots-to-cost-3-to-10-under-african-union-vaccine-plan-idUSKBN29P0LL.Google Scholar
Mazzucato, Mariana, and Roy, Victor. 2019. “Rethinking Value in Health Innovation: From Mystifications Towards Prescriptions.” Journal of Economic Policy Reform 22 (2): 101–19.CrossRefGoogle Scholar
McGoey, Linsey. 2021. “Philanthrocapitalism and the Separation of Powers.” Annual Review of Law and Social Science 17 (1): 391–409.CrossRefGoogle Scholar
McNamara, Kathleen R., and Newman, Abraham L.. 2020. “The Big Reveal: COVID-19 and Globalization’s Great Transformations.” International Organization 74 (S1): E59–E77.CrossRefGoogle Scholar
Montinola, Gabriella R. 2010. “When does Aid Conditionality Work?” Studies in Comparative International Development 45 (3): 358–82.CrossRefGoogle Scholar
Moyo, Dambisa. 2009. Dead Aid: Why Aid is not Working and How There is a Better Way for Africa. New York: Macmillan.Google Scholar
MSF. 2022. “WTO Members must demand that any formal TRIPS waiver agreement includes waiving IP on COVID-19 treatments and diagnostics, addresses intellectual property barriers beyond patents.” Médecins Sans Frontières. https://www.doctorswithoutborders.org/latest/msf-responds-potential-compromise-trips-waiver.Google Scholar
Nachega, Jean B., Sam-Agudu, Nadia A., Masekela, Refiloe, van der Zalm, Marieke M., Nsanzimana, Sabin, Condo, Jeanine, Ntoumi, Francine, et al. 2021. “Addressing Challenges to Rolling out COVID-19 Vaccines in African Countries.” The Lancet Global Health 9 (6): e746–e748.CrossRefGoogle ScholarPubMed
Nakkazi, Esther. 2021. “Uganda Defends Price Paid For AstraZeneca COVID19 Vaccine; New Study Suggests Vaccine Could Cut Transmission By Two-Thirds.” Health Policy Watch. https://healthpolicy-watch.news/uganda-defends-astrazeneca-price-says-its-not-higher-than-other-countries/.Google Scholar
Nhemachena, Artwell, Kangira, J., and Mlambo, N.. 2018. “Chapter One. Materialities and the Resilient Global Frontierisation of Africa: An Introduction.” In Decolonisation of Materialities or Materialisation of (Re-) Colonisation. Symbolisms, Languages, Ecocriticism and (Non) Representationalism in Twenty-First Century Africa: 1–53.Google Scholar
Nkrumah, Kwame. 1965. Neo-colonialism: The Last Stage of Imperialism. London: Thomas Nelson & Sons, Ltd.Google Scholar
Nordling, Linda. 2020. “Africa’s Pandemic Puzzle: Why so Few Cases and Deaths?” Science 756–57.CrossRefGoogle Scholar
Okwonga, Musa. 2020. “The French doctors who wanted to test vaccines on Africans and Western medicine’s dark history.” Quartz Africa. qz.com/Africa/1836272/French-doctors-say-test-COVID-19-vaccine-on-africans-spark-fury/.Google Scholar
Orangi, Stacey, Pinchoff, Jessie, Mwanga, Daniel, Abuya, Timothy, Hamaluba, Mainga, Warimwe, George, Austrian, Karen, and Barasa, Edwine. 2021. “Assessing the Level and Determinants of COVID-19 Vaccine Confidence in Kenya.” Vaccines 9 (8): 936.CrossRefGoogle ScholarPubMed
Padma, T. V. 2021 “COVID Vaccines to Reach Poorest Countries in 2023—Despite Recent Pledges.” Nature 595 (7867): 342–43.CrossRefGoogle Scholar
Partners in Health. 2022. https://www.pih.org/article/moral-failure-global-vaccine-inequity-hits-africa-hardest.Google Scholar
Peralta, Eyder. 2021. “Vaccination Efforts in Sub-Saharan Africa Echo AIDS Epidemic.” NPR. https://www.npr.org/2021/02/16/968457175/vaccination-efforts-in-sub-saharan-africa-echo-aids-epidemic.Google Scholar
Piot, Charles. 2010. Nostalgia for the Future: West Africa After the Cold War. Chicago: University of Chicago Press.CrossRefGoogle Scholar
Reuters. 2022. “South Africa to Get $474m World Bank Loan for COVID Vaccines.” https://www.reuters.com/world/africa/world-bank-approves-474-mln-loan-safrica-COVID-vaccines-2022-06-14/.Google Scholar
Riaz, Mehr Muhammad Adeel, Ahmad, Unaiza, Mohan, Anmol, dos Santos Costa, Ana Carla, Khan, Hiba, Babar, Maryam Salma, Hasan, Mohammad Mehedi, Essar, Mohammad Yasir, and Zil-E-Ali, Ahsan. 2021. “Global Impact of Vaccine Nationalism during COVID-19 Pandemic.” Tropical Medicine and Health 49 (1): 1–4.CrossRefGoogle ScholarPubMed
Roy, Rajesh, and Agarwal, Vibhuti. 2021. “India Suspends COVID-19 Vaccine Exports to Focus on Domestic Immunization.” The Wall Street Journal. wsj.com/articles/india-suspends-COVID-19-vaccine-exports-to-focus-on-domestic-immunization-11616690859.Google Scholar
Rubin, Paul H. 2009. “Altruism and Self Interest in Medical Decision Making.” Journal of Law, Medicine & Ethics 37 (3): 401–9.CrossRefGoogle ScholarPubMed
Salyer, Stephanie J., Maeda, Justin, Sembuche, Senga, Kebede, Yenew, Tshangela, Akhona, Moussif, Mohamed, Ihekweazu, Chikwe, et al. 2021. “The first and second waves of the COVID-19 pandemic in Africa: a cross-sectional study.” The Lancet 397 (10281): 1265–75.CrossRefGoogle ScholarPubMed
Schwab, Tim. 2020. “While the Poor Get Sick, Bill Gates Just Gets Richer.” The Nation. https://www.thenation.com/article/economy/bill-gates-investments-COVID/.Google Scholar
Schwartz, Herman Mark. 2017. “Club Goods, Intellectual Property Rights, and Profitability in the Information Economy.” Business and Politics 19 (2): 191–214.CrossRefGoogle Scholar
Sekalala, Sharifah, Forman, Lisa, Hodgson, Timothy, Mulumba, Moses, Namyalo-Ganafa, Hadijah, and Meier, Benjamin Mason. 2021. “Decolonising human rights: how intellectual property laws result in unequal access to the COVID-19 vaccine.” BMJ Global Health 6 (7): e006169.Google ScholarPubMed
Sell, Susan. 2020. “What COVID-19 Reveals About Twenty-First Century Capitalism: Adversity and Opportunity.” Development 63 (1): 150–56.CrossRefGoogle ScholarPubMed
Sidibé, Michael. 2022. “Vaccine Equity: Ensuring Africa is not Left Out.” Brookings Institute. https://www.brookings.edu/blog/africa-in-focus/2022/01/24/vaccine-inequity-ensuring-africa-is-not-left-out/.Google Scholar
Sklair, Jessica, and Gilbert, Paul. 2022. “Giving as ‘De-Risking’: Philanthropy, Impact Investment and the Pandemic Response.” Public Anthropologist 4 (1): 51–77.CrossRefGoogle Scholar
Stasik, Michael, Hänsch, Valerie, and Mains, Daniel. 2020. “Temporalities of Waiting in Africa.” Critical African Studies 12 (1): 1–9.CrossRefGoogle Scholar
Thambisetty, Sivaramjani. 2021. “Vaccines and Patents: How Self-interest and Artificial Scarcity Weaken Human Solidarity.” British Politics and Policy at LSE.Google Scholar
Tiwari, Shubhangi, Dasari, Isha, and Nayar, Gayetri. 2020. “Stuck in Limbo: (In)Hospitality in the West Towards Migrants.” http://ashokairsoc.com/stuck-in-limbo-inhospitality-of-the-west-towards-migrants/.Google Scholar
Udofia, O. E. 1984. “Imperialism in Africa: A Case of Multinational Corporations.” Journal of Black Studies 14 (3): 353–68.CrossRefGoogle Scholar
Uzoigwe, Godfrey N. 2019. “Neocolonialism is Dead: Long Live Neocolonialism.” Journal of Global South Studies 36 (1): 59–87.CrossRefGoogle Scholar